EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice

Stefan Hadzic, Cheng-Yu Wu iD, Marija Gredic, Oleg Pak, Edma Loku, Simone Kraut iD, Baktybek Kojonazarov, Jochen Wilhelm iD, Monika Brosien, Mariola Bednorz, Michael Seimetz, Andreas Günther iD und 11 weitere

European Respiratory Journal · 2023-11 · 62 (5) · 2201606

DOI: 10.1183/13993003.01606-2022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 26.10.2023. Verfasst von Stefan Hadzic und 22 weiteren Autor:innen. Beteiligte Einrichtung: Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Re…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Hypertension, Pulmonary, Cigarette Smoking, Pulmonary Emphysema. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

COPD is an incurable disease and a leading cause of death worldwide. In mice, fibroblast growth factor (FGF)10 is essential for lung morphogenesis, and in humans, polymorphisms in the human FGF10 gene correlate with an increased susceptibility to develop COPD.

Methods

We analysed FGF10 signalling in human lung sections and isolated cells from healthy donor, smoker and COPD lungs. The development of emphysema and PH was investigated in Fgf10 +/− and Fgfr2b +/− (FGF receptor 2b) mice upon chronic exposure to cigarette smoke. In addition, we overexpressed FGF10 in mice following elastase- or cigarette smoke-induced emphysema and pulmonary hypertension (PH).

Results

We found impaired FGF10 expression in human lung alveolar walls and in primary interstitial COPD lung fibroblasts. In contrast, FGF10 expression was increased in large pulmonary vessels in COPD lungs. Consequently, we identified impaired FGF10 signalling in alveolar walls as an integral part of the pathomechanism that leads to emphysema and PH development: mice with impaired FGF10 signalling ( Fgf10 +/− and Fgfr2b +/− ) spontaneously developed lung emphysema, PH and other typical pathomechanistic features that generally arise in response to cigarette smoke exposure.

Conclusion

In a therapeutic approach, FGF10 overexpression successfully restored lung alveolar and vascular structure in mice with established cigarette smoke- and elastase-induced emphysema and PH. FGF10 treatment triggered an initial increase in the number of alveolar type 2 cells that gradually returned to the basal level when the FGF10-mediated repair process progressed. Therefore, the application of recombinant FGF10 or stimulation of the downstream signalling cascade might represent a novel therapeutic strategy in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveHypertension, PulmonaryCigarette SmokingPulmonary EmphysemaEmphysemaHumansAnimalsMicePancreatic ElastaseFibroblast Growth Factor 10Receptor, Fibroblast Growth Factor, Type 2LungMice, Inbred C57BL

Substanzen

Pancreatic ElastaseFibroblast Growth Factor 10Receptor, Fibroblast Growth Factor, Type 2

Autor:innen und Institutionen

  • Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany.
  • Institute for Lung Health (ILH), Justus-Liebig-University, Giessen, Germany.
  • Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, P.R. China.

ORCID-Profile: Cheng-Yu Wu, Simone Kraut, Jochen Wilhelm, Andreas Günther, Hossein A Ghofrani, Ralph T Schermuly, Werner Seeger, Elie El Agha

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Hadzic, S., Wu, C. Y., Gredic, M., Pak, O., Loku, E., Kraut, S., Kojonazarov, B., Wilhelm, J., Brosien, M., Bednorz, M., Seimetz, M., Günther, A., Kosanovic, D., Sommer, N., Warburton, D., Li, X., Grimminger, F., Ghofrani, H. A., Schermuly, R. T., …, & Weissmann, N. (2023). Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice. European Respiratory Journal, 62(5), 2201606. https://doi.org/10.1183/13993003.01606-2022

Vancouver

Hadzic S, Wu CY, Gredic M, Pak O, Loku E, Kraut S, et al. Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice. European Respiratory Journal. 2023;62(5):2201606. doi:10.1183/13993003.01606-2022

BibTeX
@article{Hadzic2023,
  author = {Hadzic, Stefan and Wu, Cheng-Yu and Gredic, Marija and Pak, Oleg and Loku, Edma and Kraut, Simone and Kojonazarov, Baktybek and Wilhelm, Jochen and Brosien, Monika and Bednorz, Mariola and Seimetz, Michael and Günther, Andreas and Kosanovic, Djuro and Sommer, Natascha and Warburton, David and Li, Xiaokun and Grimminger, Friedrich and Ghofrani, Hossein A and Schermuly, Ralph T and Seeger, Werner and El Agha, Elie and Bellusci, Saverio and Weissmann, Norbert},
  title = {Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice},
  journal = {European Respiratory Journal},
  year = {2023},
  volume = {62},
  number = {5},
  pages = {2201606},
  doi = {10.1183/13993003.01606-2022}
}
Kostenlos starten →